SCHEMBL7209571

SCHEMBL7209571

CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)c1nccs1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.41
HSPA9 P38646 1/20 0.40
PREP P48147 2/20 0.40
ELANE P08246 7/20 0.39
XIAP P98170 3/20 0.39
MLX Q9UH92 1/20 0.39
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
NR1I2 O75469 1/20 0.36
ABCB11 O95342 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
OPRK1 P41145 1/20 0.36
KCNH2 Q12809 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ADAM17 P78536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1718165 0.94 XIAP (0.47) HTTELANEXIAPMLXDPP4
SCHEMBL4408100 0.84 CMA1 (0.44) ELANEMEN1KMT2A
SCHEMBL2769300 0.80 XIAP (0.44) PREPELANEXIAPMLXCYP3A4
SCHEMBL8344004 0.77 DPP4 (0.46) HTTDPP4DPP8DPP9KCNH2
SCHEMBL2768336 0.77 DPP4 (0.50) PREPELANEXIAPMLXDPP4
SCHEMBL30052033 0.77 ACE (0.51) XIAPDPP4DPP8DPP9MEN1
Bromide SCHEMBL1509660 0.76 DPP4 (0.49) PREPELANEXIAPMLXDPP4
Trifluoroacetic Acid SCHEMBL1509589 0.75 XIAP (0.53) ELANEXIAPMLXMEN1KMT2A
Trifluoroacetic Acid SCHEMBL27641390 0.75 XIAP (0.53) ELANEXIAPMLXMEN1KMT2A
SCHEMBL13380009 0.75 XIAP (0.47) ELANEXIAPMLXDPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030148961-A1 Peptidyl ketones as inhibitors of DPIV PROSIDION LIMITED (GB) 2003-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030148961-A1 Peptidyl ketones as inhibitors of DPIV GLS, SLC5A1, BCKDK HTT 3945/4885HSPA9 378/4885PREP 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.